| Literature DB >> 26271194 |
Nina Worel1, Andreas Buser2, Hildegard T Greinix3, Hans Hägglund4, Willis Navarro5, Michael A Pulsipher6, Grazia Nicoloso de Faveri7, Mats Bengtsson8, Annelies Billen9, German Espino10, Mirjam Fechter11, Valeria Giudice12, Kristina Hölig13, Heiwa Kanamori14, Yoshihisa Kodera15, Gerda Leitner16, Tanja Netelenbos17, Dietger Niederwieser18, Suzanna M van Walraven19, Vanderson Rocha20, Tigran Torosian21, Carmen Vergueiro22, Daniel Weisdorf23, Hiromasa Yabe24, Jörg P Halter25.
Abstract
The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year continues to increase. Advances in HLA typing, better supportive care, and administration of reduced-intensity conditioning regimens allow treatment of older patients with older sibling donors. Pretransplant donor assessment and testing are very important processes affecting the quality and safety of donation. For unrelated HSC donors detailed recommendations for health assessment have been published, allowing donation only if they are unrestrictedly healthy. Eligibility criteria for related donors are less strict and vary significantly between centers. In situations where a family donor does not meet the suitability criteria for unrelated donors, involved physicians often struggle with the decision whether the matched relative is suitable for donation or not. On behalf of the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues, we intended to develop a consensus document with recommendations for donor workup and final clearance of family donors who would not be able to serve as unrelated donors because of their age or pre-existing diseases. This article covers different topics intending to support decision-making, with the goal of minimizing medical risk to the donor and protection of the recipient from transmissible diseases.Entities:
Keywords: Related stem cell donor; Suitability criteria
Mesh:
Year: 2015 PMID: 26271194 DOI: 10.1016/j.bbmt.2015.08.009
Source DB: PubMed Journal: Biol Blood Marrow Transplant ISSN: 1083-8791 Impact factor: 5.742